Real-World data (RWD) of physician's advice on BRCA genetic testing for ovary (OC) and breast cancer (BC) patients (pts).

被引:0
|
作者
Vorobiof, Daniel A. [1 ]
机构
[1] Belong Life, New York, NY USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e19357
引用
收藏
页数:1
相关论文
共 50 条
  • [21] The prognostic role of tumour inflammation markers in patients (pts) with colorectal cancer (CRC) treated with trifluridine/tipiuracil hydrochloride: Real-world data (RWD) from Greater Manchester
    Alchawaf, A.
    Dawood, M.
    Al-Ani, M.
    Ho, A.
    Ferrera, A.
    Saunders, M.
    Tinsley, N.
    Nasralla, M.
    Paton, N.
    Wilson, G.
    Braun, M.
    Alam, N.
    Hasan, J. H.
    Marti, F. Marti
    Kamposioras, K.
    Mullamitha, S.
    Barriuso, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S438 - S438
  • [22] Clinical outcomes in patients ( pts) with estrogen receptor (ER) plus stage I breast cancer (BC) and Recurrence Score (RS) 26-30: Real-world data
    Rotem, O.
    Peretz, I.
    Leviov, M.
    Kuchuk, I.
    Itay, A.
    Tokar, M.
    Paluch-Shimon, S.
    Maimon, O.
    Yerushalmi, R.
    Drumea, K.
    Evron, E.
    Sonnenblick, A.
    Gal-Yam, E.
    Goldvaser, H.
    Yosef, S.
    Merose, R.
    Bareket-Samish, A.
    Soussan-Gutman, L.
    Stemmer, S. M.
    BREAST, 2023, 68 : S81 - S82
  • [23] BRCA testing and PARP inhibitor utilization in real-world HER2negative metastatic breast cancer
    Yadav, Siddhartha
    Hillman, Sam
    Luo, Linlin
    Li, Weiyan
    Earla, Jagadeswara
    Xu, Xiaoqing
    CANCER RESEARCH, 2024, 84 (09)
  • [24] A retrospective analysis of real-world tumor BRCA (tBRCA) testing trends in ovarian cancer (OC) before and after PARP inhibitor approvals
    Randall, L. M.
    Aydin, E.
    Louie-Gao, M.
    Hazard, S.
    Westin, S. N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 809 - 810
  • [25] Low rates of BRCA1 and BRCA2 testing for patients with ovarian cancer in ASCO's CancerLinQ, a real-world database.
    Dewdney, Summer
    Potter, Danielle
    Haidle, Joy Larsen
    Hulick, Peter J.
    Riffon, Mark
    Monzon, Federico A.
    Keole, Sameer R.
    Miller, Robert S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [26] Real-world treatment patterns among metastatic breast cancer patients by BRCA status and phenotype.
    Sebby, Wendy
    Liede, Alexander
    Mazumder, Debasish
    Ghosh, Anirban
    Papademetriou, Eros
    Potluri, Ravi C.
    Bach, Bruce Allen
    Tyczynski, Jerzy Edward
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [27] Real-world data of multiple diagnostic biomarker testing for lung cancer patients in Japan
    Yatabe, Yasushi
    Nishio, Makoto
    Takahashi, Toshiaki
    Nishino, Kazumi
    Yoshiki, Yasumasa
    Togo, Kanae
    Emir, Birol
    Iadeluca, Laura
    Nishio, Kazuto
    ANNALS OF ONCOLOGY, 2021, 32 : S300 - S300
  • [28] Real-World Data of NGS Diagnostic Biomarker Testing for Lung Cancer Patients in Japan
    Takahashi, T.
    Nishio, M.
    Yatabe, Y.
    Nishino, K.
    Yoshiki, Y.
    Shiraiwa, N.
    Emir, B.
    Iadeluca, L.
    Nishio, K.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1151 - S1152
  • [29] Real-world patterns of genomic testing in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Shore, N.
    Ionescu-Ittu, R.
    Yang, L.
    Laliberte, F.
    Payne, S.
    Gayle, A.
    Amin, S.
    Mahendran, M.
    Lejeune, D.
    Yu, L.
    Burgents, J.
    Duh, M. S.
    Ghate, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S526 - S527
  • [30] Real-world data analysis of ovarian cancer (OC) maintenance utilization among maintenance eligible patients.
    Garofalo, David
    Aydin, Ebru
    Labrador, Monica
    Webster, Jennifer
    Brown, Greg
    Donaldson, Joseph
    Gierman, Hinco Jasper
    Varughese, Prateesh
    Malik, Ash
    Scott, Jeffrey A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)